Glioma and prostate cancer
Conditions
Interventions
Index test:artificial 
intelligence 
diagnosis 
model 
based 
on 
deep 
learning 
tumor 
heterogeneity 
imaging 
Sponsors
Zhongnan Hospital of Wuhan University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Patients with glioma: 1. The age range of the experimental subjects is between 18 and 65 years old. 2. Gender is controlled at 1:1, 50 female glioma patients and 50 male glioma patients, 3. The condition is stable and there are no other metabolic diseases, brain trauma or comorbidities. 4. Brain tumor surgery will be performed within a month. 5. A transcranial magnetic resonance scan showed nodules no smaller than 1 cm. 6. The tumor site should be supracurvature glioma (cerebral hemispheric glioma) or subcurvature glioma (cerebellar glioma), including frontal lobe, parietal lobe, temporal lobe, occipital lobe, semi-oval center, basal ganglia, thalamus And corpus callosum tumors, or other types of brain tumors above and below the curtain. 7. Sign informed consent. Patients with prostate cancer: 1. The age range of the test subjects is between 18 and 65 years old. 2. The condition is stable and there are no other metabolic diseases, trauma or comorbidities. Prostate cancer surgery will be 2/. rformed within a month. 3. Plain magnetic resonance scan showed nodules no smaller than 0.5cm. 4. Sign informed consent.
Exclusion criteria
Exclusion criteria: Patients with glioma: 1. Exclude test subjects who cannot cooperate with the magnetic resonance examination due to their own reasons, such as metallic foreign bodies, claustrophobia or mental disorder. 2. Because the diffusion sequence is susceptible to magnetically sensitive artifacts, it excludes brainstem and spinal cord tumors, and types of brain tumors close to the sella, cerebellopontine angle, pituitary, skull base, and orbit. 3. Patients who have undergone conventional treatments for brain tumors such as surgery, medication, or radiotherapy. Patients with prostate cancer: 1. Exclude the test subjects who cannot complete the magnetic resonance examination due to their own reasons, such as metallic foreign bodies and claustrophobia. 2. Exclude patients who have undergone surgery, drug therapy, radiotherapy and other conventional tumor treatments.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| AUC value;ROC curve; | — |
Secondary
| Measure | Time frame |
|---|---|
| F1-SOCRE;accuracy rate;recall rate;Precision-recall curve;Kolmogorov-Smirnov value; | — |
Countries
China
Contacts
Public ContactHaibo Xu
Outcome results
None listed